JP2025513501A5 - - Google Patents
Info
- Publication number
- JP2025513501A5 JP2025513501A5 JP2024562210A JP2024562210A JP2025513501A5 JP 2025513501 A5 JP2025513501 A5 JP 2025513501A5 JP 2024562210 A JP2024562210 A JP 2024562210A JP 2024562210 A JP2024562210 A JP 2024562210A JP 2025513501 A5 JP2025513501 A5 JP 2025513501A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutically acceptable
- acceptable salt
- solid composition
- aqueous composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263333557P | 2022-04-22 | 2022-04-22 | |
| US63/333,557 | 2022-04-22 | ||
| EP22173920.4 | 2022-05-17 | ||
| EP22173920 | 2022-05-17 | ||
| PCT/EP2023/060686 WO2023203255A1 (en) | 2022-04-22 | 2023-04-24 | Freeze dried compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513501A JP2025513501A (ja) | 2025-04-24 |
| JP2025513501A5 true JP2025513501A5 (cg-RX-API-DMAC7.html) | 2026-05-08 |
Family
ID=86330122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562210A Pending JP2025513501A (ja) | 2022-04-22 | 2023-04-24 | 凍結乾燥組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250275967A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4511007A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025513501A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119403545A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3249784A1 (cg-RX-API-DMAC7.html) |
| TW (2) | TW202406551A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023203257A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
| EP2330213A1 (en) | 2003-03-05 | 2011-06-08 | Halozyme, Inc. | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| PT3366278T (pt) | 2006-06-23 | 2024-10-21 | Janssen Sciences Ireland Unlimited Co | Suspensões aquosas de tmc278 |
| BRPI0715113A2 (pt) * | 2006-07-26 | 2013-06-04 | Sandoz Ag Sandoz Sa Sandoz Ltd | formulaÇço de caspofungina |
| AR065720A1 (es) * | 2007-03-14 | 2009-06-24 | Tibotec Pharm Ltd | Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso. |
| GB2513060B (en) * | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| HRP20201241T1 (hr) * | 2011-04-15 | 2020-11-27 | Janssen Pharmaceutica N.V. | Nanosuspenzije lijeka osušene zamrzavanjem |
| WO2018013673A1 (en) * | 2016-07-13 | 2018-01-18 | Reform Biologics, Llc | Stabilizing excipients for therapeutic protein formulations |
| WO2022109555A1 (en) | 2020-11-17 | 2022-05-27 | Janssen Sciences Ireland Unlimited Company | Treatment or prevention of hiv infection |
-
2023
- 2023-04-24 WO PCT/EP2023/060688 patent/WO2023203257A1/en not_active Ceased
- 2023-04-24 JP JP2024562210A patent/JP2025513501A/ja active Pending
- 2023-04-24 TW TW112115224A patent/TW202406551A/zh unknown
- 2023-04-24 TW TW112115222A patent/TW202408580A/zh unknown
- 2023-04-24 EP EP23722287.2A patent/EP4511007A1/en active Pending
- 2023-04-24 CA CA3249784A patent/CA3249784A1/en active Pending
- 2023-04-24 US US18/858,037 patent/US20250275967A1/en active Pending
- 2023-04-24 CN CN202380048657.2A patent/CN119403545A/zh active Pending
- 2023-04-24 WO PCT/EP2023/060686 patent/WO2023203255A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chaturvedi et al. | A review on mucoadhesive polymer used in nasal drug delivery system | |
| JP2023537609A5 (cg-RX-API-DMAC7.html) | ||
| JP2013511557A5 (cg-RX-API-DMAC7.html) | ||
| AU2008225501B2 (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
| JP4902103B2 (ja) | 凍結乾燥フォームによる生物活性材料の保存 | |
| WO1991000739A1 (en) | Stable motilin preparation | |
| JP2007504129A5 (cg-RX-API-DMAC7.html) | ||
| IL255113B (en) | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them | |
| JPH11506100A (ja) | ミソプロストールの安定化された分散系 | |
| JP2019519570A5 (cg-RX-API-DMAC7.html) | ||
| JP2000515543A (ja) | ヘルペスウイルスにより起こる感染を予防または治療するためのキトサンと組み合わされたヘパリンまたはヘパラン硫酸の使用 | |
| KR20190092481A (ko) | 은 및 셀레늄을 포함하는 항생제 조성물 | |
| JP6488003B2 (ja) | 安定なモンテルカスト溶液 | |
| ES2279172T3 (es) | Nanoparticulas para la administracion de ingredientes activos, procedimiento para la elaboracion de dichas particulas y composiciones que las contienen. | |
| KR20090057400A (ko) | 트롬빈 수용체 길항제의 동결건조된 신속 붕해성 경구 제형 | |
| JPS59181224A (ja) | 安定なインタ−フエロン製剤の製法 | |
| CN101991541A (zh) | 阿昔洛韦-壳聚糖纳米粒的制备方法 | |
| JP5373616B2 (ja) | 鳥インフルエンザウイルス感染の予防的治療のためのポリiclcカプセル化リポソーム | |
| CN101804031A (zh) | 一种利巴韦林-壳聚糖季铵盐纳米微粒的制备方法 | |
| CN101534821B (zh) | 室温稳定的冻干可注射的半合成长春花生物碱类和糖类的药物组合物 | |
| JP2025513502A5 (cg-RX-API-DMAC7.html) | ||
| CN104721136A (zh) | 一种布佐林胺眼用纳米混悬剂及其制备方法 | |
| JP2022548221A5 (cg-RX-API-DMAC7.html) | ||
| JP2025502242A5 (cg-RX-API-DMAC7.html) | ||
| CN104721145A (zh) | 一种布佐林胺纳米粒眼用制剂及其制备方法 |